LXEO   $11.14  22.42% Market Closed After Close 10.9 -2.15%

Lexeo Therapeutics Inc
Total Cash 174.98M
totalCashPerShare 5.293
EBITDA -81.46M
Total Debt 10.85M
quickRatio 9.27
currentRatio 9.384
Total Revenue
debtToEquity 6.579
Revenue/Share
ROA -0.39933997
ROE -0.74834996
grossProfits
freeCashflow -36.83M
operatingCashflow -62.95M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 138.38M
forwardPE -3.0298011
floatShares 16.98M
sharesOutstanding 33.06M
sharesShort 2.07M
sharesShortPriorMonth 1.24M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.91%
Short Ratio help_outline 5.89%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 4.992
Price To Book help_outline 1.83
earningsQuarterlyGrowth
netIncomeToCommon -77.22M
trailingEps -12.84%
forwardEps -3.02%
enterpriseToEbitda -1.70
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.69 3Q 2024
institutionsCount 85
lastUpdated Oct. 17, 2024, 12:37 p.m.